Robert E. Waltermire, Senior VP, Chief Pharma Dev: Madrigal Pharmaceuticals MDGL Sell · Filed 25/03/04

Trade details

Type: Insider sale
Amount: $358,721.48
Shares · price: 1,052 sh · $340.99 a share
Held after: 3,903 sh
Stock: Madrigal Pharmaceuticals MDGL
Person: Robert E. WaltermireSenior VP, Chief Pharma Dev
Trade date: 25/02/28
Filed: 25/03/04
Days to filing: 4 days

Sold 21.2% of holdings

Share of holding sold: 21.2%

Madrigal Pharmaceuticals trades, last 26 weeks

What else happened in Madrigal Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/01/29~25/03/30

Robert E. Waltermire's recent trades

Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$1.6M
4,701 sh
$1.6M
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$598.5K
1,777 sh
$598.5K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$564.6K
1,657 sh
$564.6K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$486.8K
1,412 sh
$486.8K
Filed 25/03/07
Traded 25/03/05
Robert E. WaltermireSenior VP, Chief Pharma Dev
SellMadrigal Pharmaceuticals
Sell
Madrigal Pharmaceuticals
MDGL
$387.5K
1,146 sh
$387.5K
Filed 25/03/07
Traded 25/03/05

Robert E. Waltermire, Chief Officer — sold $358.7K of Madrigal Pharmaceuticals MDGL · 21.2% of holdings | Whalegun